Schoenberg Mark 4
4 · UroGen Pharma Ltd. · Filed Jun 11, 2025
Insider Transaction Report
Form 4
Schoenberg Mark
Chief Medical Officer
Transactions
- Exercise/Conversion
Ordinary Shares
2025-06-08+10,000→ 158,540 total - Exercise/Conversion
Restricted Stock Units
2025-06-08−10,000→ 10,000 total→ Ordinary Shares (10,000 underlying) - Sale
Ordinary Shares
2025-06-09$7.37/sh−5,162$38,044→ 153,378 total
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.
- [F2]Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units.
- [F3]The reporting person was granted RSUs on June 8, 2023 representing 30,000 ordinary shares. The RSUs will vest in three equal annual installments from June 8, 2024.